Stocksigma LogoStocksigma Logo

Gennex Laboratories Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh)

■ Revenue: 4,404 (+12.1% YoY | +5.2% QoQ) ■ EBITDA: 707 (-6.5% YoY | +10.7% QoQ) ■ EBITDA Margin (%): 16.0 (-318 bps YoY | +79 bps QoQ) ■ PAT: 413 (-18.0%

Gennex Laboratories Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh)

Gennex Laboratories Ltd · Financial Result · 14 Nov 2026, 11:49 pm

Gennex Laboratories Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh) ■ Revenue: 4,404 (+12.1% YoY | +5.2% QoQ) ■ EBITDA: 707 (-6.5% YoY | +10.7% QoQ) ■ EBITDA Margin (%): 16.0 (-318 bps YoY | +79 bps QoQ) ■ PAT: 413 (-18.0% YoY | -4.5% QoQ) ■ EPS (INR): 0.17 (-17.9% YoY | -11.5% QoQ)

Original exchange filing (PDF)

More announcements from Gennex Laboratories Ltd

All Gennex Laboratories Ltd announcements